Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management intype 2 diabetes

R.E. van Genugten, D.L. Moller-Goede, D.H. van Raalte, M. Diamant

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	593-606
Journal	Diabetes, Obesity and Metabolism
Volume	15
Issue number	7
DOIs	https://doi.org/10.1111/dom.12050
Publication status	Published - 2013

Access to Document

@article{79f80c71311547f3aab72b65ec4c6663,

title = "Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management intype 2 diabetes",

author = "{van Genugten}, R.E. and D.L. Moller-Goede and {van Raalte}, D.H. and M. Diamant",

year = "2013",

doi = "10.1111/dom.12050",

language = "Undefined/Unknown",

volume = "15",

pages = "593--606",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell",

number = "7",

}

TY - JOUR

T1 - Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management intype 2 diabetes

AU - van Genugten, R.E.

AU - Moller-Goede, D.L.

AU - van Raalte, D.H.

AU - Diamant, M.

PY - 2013

Y1 - 2013

U2 - 10.1111/dom.12050

DO - 10.1111/dom.12050

M3 - Article

C2 - 23216746

VL - 15

SP - 593

EP - 606

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 7

ER -